# AstraZeneca Pharmaceuticals LP, Wilmington, DE – FDA Inspections

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/ca124104-cef7-4863-bbb7-14b5f7bfd1b5

> Inspection records and compliance data for AstraZeneca Pharmaceuticals LP in Wilmington, Delaware. 12 FDA inspections on record, last inspected October 04, 2024.

---

## Details

- Name: AstraZeneca Pharmaceuticals LP
- FEI Number: 2518137
- Address Line 1: 1800 Concord Pike
- City: Wilmington
- State: Delaware
- Zip Code: 19897
- Country Name: United States
- Address: 1800 Concord Pike, Wilmington, Delaware 19897, United States
- Country: United States

## Related Documents

- FDA Inspection 1247294 - AstraZeneca Pharmaceuticals LP - 2024-10-04 — source: FDA, date: October 4, 2024
- FDA Inspection 1247294 - AstraZeneca Pharmaceuticals LP - 2024-10-04 — classification: No Action Indicated (NAI), source: FDA, date: October 4, 2024
- FDA Inspection 1219696 - AstraZeneca Pharmaceuticals LP - 2023-09-20 — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2023
- FDA Inspection 930780 - AstraZeneca Pharmaceuticals LP - 2015-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2015
- FDA Inspection 930780 - AstraZeneca Pharmaceuticals LP - 2015-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2015
- FDA Inspection 895234 - AstraZeneca Pharmaceuticals LP - 2014-08-26 — classification: No Action Indicated (NAI), source: FDA, date: August 26, 2014
- FDA Inspection 873394 - AstraZeneca Pharmaceuticals LP - 2014-04-07 — classification: No Action Indicated (NAI), source: FDA, date: April 7, 2014
- FDA Inspection 827010 - AstraZeneca Pharmaceuticals LP - 2013-04-12 — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2013
- FDA Inspection 800868 - AstraZeneca Pharmaceuticals LP - 2012-09-27 — classification: No Action Indicated (NAI), source: FDA, date: September 27, 2012
- FDA Inspection 790121 - AstraZeneca Pharmaceuticals LP - 2012-06-18 — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2012

## Related Companies

- [Synergy Rx Express Pharmacy LLC](https://www.keypedia.com/companies/synergy-rx-express-pharmacy-llc/69db0958-1ec3-4094-977b-2c7be79897b9)
- [Speakman Co](https://www.keypedia.com/companies/speakman-co/ff58960d-36fa-448c-93b1-27b91357f072)
- [Croda Atlas Point](https://www.keypedia.com/companies/croda-atlas-point/6601c33e-92a4-45ec-90fe-38345b2d8587)
- [Foresee Pharmaceuticals Co., Ltd](https://www.keypedia.com/companies/foresee-pharmaceuticals-co-ltd/a4b426bc-74f9-496b-ad44-1ca6f9efe241)
- [Lincare, Inc.](https://www.keypedia.com/companies/lincare-inc/0d8c4cba-d946-41a6-9c52-e8717f74782d)
- [Beebe Medical Center Incorporated IRB](https://www.keypedia.com/companies/beebe-medical-center-incorporated-irb/524dc0bd-0796-41bc-b425-d47f4e4c1557)
- [Snow Pharmaceuticals LLC](https://www.keypedia.com/companies/snow-pharmaceuticals-llc/d7100623-e65d-4722-9fa7-256587a53c05)
- [Edell,Steven L Do](https://www.keypedia.com/companies/edellsteven-l-do/e4a03e68-204e-4915-9a7b-de52ef6d0ae1)
- [UPS Supply Chain Solutions, Inc.](https://www.keypedia.com/companies/ups-supply-chain-solutions-inc/ca268f3b-d9d4-46c0-a541-362e57b841ad)
- [Element Materials Technology Wilmington](https://www.keypedia.com/companies/element-materials-technology-wilmington/9a3f343c-a6c9-4864-9335-fbcba74c8d02)
